Research, development and strategic partnering for the global vaccine industry

29-31 October 2018, EPIC SANA Lisboa Hotel, Lisbon, Portugal

SPONSOR NOW

REGISTER NOW
Research, development and strategic partnering for the global vaccine industry

29-31 October 2018, EPIC SANA Lisboa Hotel, Lisbon, Portugal

SPONSOR NOW

REGISTER NOW
Research, development and strategic partnering for the global vaccine industry

29-31 October 2018, EPIC SANA Lisboa Hotel, Lisbon, Portugal

SPONSOR NOW

REGISTER NOW
Research, development and strategic partnering for the global vaccine industry

29-31 October 2018, EPIC SANA Lisboa Hotel, Lisbon, Portugal

SPONSOR NOW

REGISTER NOW

INTRODUCING THE 2018 KEY SPEAKER

Lord James (Jim) O’Neil
Honorary Professor of Economics
University of Manchester & Author of AMR Review UK

Lord James (Jim) O’Neil

New vaccine & immuno-oncology profiling technology is
changing the whole industry

Make sure you are at the forefront of the vaccines industry. No matter where your interest lies, we have content, networking and potential partners for you.

By bringing eight tracks together under one roof, you get to choose the sessions which are the most applicable to help your business plan for the future of vaccine research, development and manufacture.

Take just three days out of the office to meet over 500+ potential customers who need to find solutions to their challenges.
Build three days of totally tailored content and attendees.

INCLUDING

Therapeutic Vaccines

Anti-Microbial Resistance

SPONSOR NOW

DOWNLOAD PROSPECTUS

Key Speakers in 2018

Lord James (Jim) O’Neil, Honorary Professor of Economics at the University of Manchester & author of AMR review UK Lord James (Jim) O’Neil
Honorary Professor of Economics
University of Manchester & Author of AMR Review UK

Ana Maria Henao-Restrepo MD
Team Leader, Implementation Research Initiative for Vaccine Research
WHO

Emily Erbelding, M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH Emily Erbelding
M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases
NIAID/NIH

Dr Melanie Saville, Director of Vaccine Development, CEPI Dr Melanie Saville
Director of Vaccine Development
CEPI

Dr Thomas G. Evans, CEO, Vaccitech Dr Thomas G. Evans
CEO
Vaccitech

Dr Laszlo Radvanyi, Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology, EMD Serono Dr Laszlo Radvanyi
Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology
EMD Serono

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Ruxandra Draghia-Akli, Vice President of Vaccines Public Health & Scientific Affairs, Merck (MSD) Ruxandra Draghia-Akli
Vice President of Vaccines Public Health & Scientific Affairs
Merck (MSD)

Dr Wayne Koff, President & CEO, The Human Vaccines Project Dr Wayne Koff
President & CEO
The Human Vaccines Project

Professor Helen McShane, Professor of Vaccinology, Jenner Institute, Oxford University Professor Helen McShane
Professor of Vaccinology, Jenner Institute
Oxford University

Dr Alex Duncan
Chief Technology Officer and Head of Research
Agenus Inc

SEE ALL SPEAKERS

500+

Attendees

300+

Companies

80%

Decision makers

175+

Speakers

Conference tracks

Co-located conferences

Dr Greg Poland Invites You To Attend

"Great conference, well organized, great opportunity to network with individuals in the vaccine world."

VP Software & Electronics, LumaCyte

2018 Scientific Advisory Board

The agenda is being shaped by an industry advisory board, with members including:

Professor Albert Osterhaus
Director, Research Center for Emerging Infections and Zoonoses (RIZ)
University of Veterinary Medicine Hannover

Dr Jeffrey Almond
Former Vice President Discovery Research and Development, Sanofi and Visiting Professor
University of Oxford - Oxford Vaccine Group

Dr Jan Poolman
Head Bacterial Vaccine Discovery and Early Development
Janssen

Dr Gregory A. Poland
Director of Mayo Vaccine Research Group
Mayo Clinic and Foundation

Dr Antu Dey
Senior Director, Research & Development
International AIDS Vaccine Initiative

Dr Konrad Stradler
Head of R&D Vaccines
Boehringer Ingelheim

Dr Roy Baynes
Senior Vice President Global Clinical Development and Chief Medical Officer
MSD

Dr Nathalie Garçon
CEO & CSO
BIOASTER

Dr Cyril Gay
Senior National Program Leader, Office of National Programs
USDA

Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Dr Mahesh Kumar
Vice President, Global Biologics Research
Zoetis

Dr Bernard Vallat
Honorary Director General
Office International Des Epizooties

Dr Ralf Clemens
SVP
GRID Rio

Dr Jerald Sadoff
Senior Advisor
Janssen Infectious Diseases and Vaccines

Dr Lorne A. Babiuk
Former Vice-President
University of Alberta

Prof Roman Prymula
Professor Preventive Medicine
Charles University in Prague

Prof Hanna Nohynek
Deputy Director
Finish Public Health

Prof Fred Zepp
Medical Director and Chairman of the Department of Paediatrics
University Medicine Mainz

Dr Annaliesa Anderson
VP Bacterial Vaccines
Pfizer

Dr Joris Vandeputte
President
IABS (International Alliance for Biological Standardization)

Prof Hanneke Schuitemaker
Global Head of Viral Vaccine Discovery and Translational Medicine in the Infectious Disease and Vaccines Therapeutic Area
Janssen Vaccines